Healthcare technology company Oscar Health, Inc. (OSCR) announced Thursday its 2024 market expansion efforts for its Individual and Family Plans.Oscar will expand its innovative, member-centric plans to 165 new counties in 13 states, making high-quality and affordable healthcare a reality for more consumers.Starting in 2024, Oscar will have a footprint in 18 states and 512 counties and expand its presence in Arizona, Florida, Georgia, Illinois, Iowa, Kansas, Missouri, North Carolina, Ohio, Oklahoma, Tennessee, Texas, and Virginia..

医疗保健技术公司奥斯卡健康公司（OSCR）周四宣布其个人和家庭计划的2024年市场扩张努力。奥斯卡将其创新的，以成员为中心的计划扩展到13个州的165个新县，实现高质量和负担得起的医疗保健更多消费者的现实。从2024年开始，奥斯卡将在18个州和512个县占有一席之地，并扩大其在亚利桑那州，佛罗里达州，乔治亚州，伊利诺伊州，爱荷华州，堪萨斯州，密苏里州，北卡罗来纳州，俄亥俄州，俄克拉荷马州，田纳西州，德克萨斯州和弗吉尼亚州的存在。。

The expansion will improve access to care in underserved and rural markets through Oscar's consumer-focused technology platform.Oscar is introducing new ways of serving its fast-growing and diverse member population, with offerings including tailored plan designs with high-frequency care routing and engagement for members who suffer from chronic illness, as well as enhancements to its program for Spanish-speaking members.

通过奥斯卡以消费者为中心的技术平台，扩张将改善服务不足和农村市场获得护理的机会。奥斯卡正在推出为其快速增长和多样化的成员群体提供服务的新方法，其产品包括量身定制的计划设计，为患有慢性病的成员提供高频护理路线和参与，以及增强其西班牙语项目会员。

For comments and feedback contact: editorial@rttnews.comBusiness News.

有关意见和反馈，请联系：editorial@rttnews.comBusiness新闻。

Biotech Stocks Facing FDA Decision In October 2023

2023年10月FDA决定面临的生物技术股票

Biotech Stocks Facing FDA Decision in August 2023

2023年8月FDA决定面临的生物技术股票

Biotech Stocks Facing FDA Decision In June 2023

2023年6月FDA决定面临的生物技术股票